INNT
TOTAL INVALIDATION PROCESSED BY THE IB
21/05/2024
Voltar para busca
Dado oficial do USPTO
FLUOROPASSIV
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
21/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
31/03/2016
Data de registro
07/02/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/08/2023
Última transação
18/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Renfrewshire PA4 9RR, GB
Examinador
VAGHANI, MAYUR C
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Vascutek Limited
Representantes
JEFFREY H. GREGER ROBERTSMLOTKOWSKISAFRANCOLE&CALDERONPC
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stentsvascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissuecardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; implantable medical systemscardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic vascular graftsprosthetic endovascular graftscatheters; implantable medical devicesimplants consisting of prosthetic materialssynthetic vascular prosthesesprosthetic vascular graftssynthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materialsprosthetic vascular graftsvascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular proceduresmedical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; thoracic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent graftsstent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent graftsmedical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent graftsstent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devicesaneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systemsprosthetic cardiac valves; heart valvesprosthetic heart valves; heart valve conduitscatheters for implanting heart valves; cardiac patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; vascular patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; thin wall carotid patchessurgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patchessurgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; knitted carotid patchessurgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patchessurgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patchessurgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
30/04/2024
INPC
INVALIDATION PROCESSED
30/04/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
18/04/2024
C71T
CANCELLED SECTION 71
18/08/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/02/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/06/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/06/2017
FIMP
FINAL DISPOSITION PROCESSED
03/06/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/11/2016
PUBO
PUBLISHED FOR OPPOSITION
22/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
17/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/09/2016
ALIE
ASSIGNED TO LIE
17/09/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2016
RFNT
REFUSAL PROCESSED BY IB
05/08/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/07/2016
RFRR
REFUSAL PROCESSED BY MPU
20/07/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/07/2016
CNRT
NON-FINAL ACTION WRITTEN
19/07/2016
MAFR
APPLICATION FILING RECEIPT MAILED
19/07/2016
DOCK
ASSIGNED TO EXAMINER
15/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/07/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/07/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FLUOROPASSIV ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.